abstract |
The invention relates to the use of at least one oligosaccharide comprising from 2 to 6 oside residues, and having a galactose residue in the non-reducing terminal position, or of a derivative of such an oligosaccharide substituted by a hydrophobic residue, for the preparation of an immunomodulating medicament. It also relates to a dermato-cosmetic composition and a cosmetic treatment of hyperreactive skins. |